655 followers
@BioMedCentral Who approved this 2019 title: "zolendronic acid is not beneficial in pts with HER2- early #breastcancer" - when there was active harm from ZA, OS HR 0.468 *against* ZA, HR reported in the inverse like this #bcsm #NEOZOTAC @jrkroep https://t.